Abstract:The NLRP3 inflammasome is activated in response to different bacterial, viral, and fungal pathogens and serves as modulator of different pattern recognition receptors signaling pathways. One of the main functions of NLRP3 is to participate in IL-1β maturation which is important in the host defense against <i>Pneumocystis</i> and other fungal infections. However, dysregulation of NLRP3 and IL-1β secretion are also implicated in the pathophysiology of many auto-inflammatory disorders. Often time's inflammatory flares are preceded by infectious illnesses questioning the role of infection in autoimmune exacerbations. However, we still do not fully understand the exact role that infection or even colonization plays as a trigger of inflammation. Herein, we investigated the role of NLRP3 in circulating B-lymphocytes following activation with two major microbial antigens (β-glucan and CpG). NLRP3 was determined essential in two independent B-lymphocytes processes: pro-inflammatory cytokine secretion and antibody regulation. Our results show that the β-glucan fungal cell wall carbohydrate stimulated B-lymphocytes to secrete IL-1β in a process partially mediated by Dectin-1 activation <i>via</i> SYK and the transcription factors NF-κB and AP-1. This IL-1β secretion was regulated by the NLRP3 inflammasome and was dependent on potassium efflux and Caspase-1. Interestingly, B-lymphocytes activated by unmethylated CpG motifs, found in bacterial and fungal DNA, failed to induce IL-1β. However, B-lymphocyte stimulation by CpG resulted in NLRP3 and Caspase-1 activation and the production and secretion of IgM antibodies. Furthermore, CpG-stimulated IgM secretion, unlike β-glucan-mediated IL-1β production, was mediated by the mammalian target of rapamycin (mTOR). Inhibition of NLRP3 and the mTOR pathway in CpG activated B-lymphocytes resulted in impaired IgM secretion suggesting their participation in antibody regulation. In conclusion, this study describes a differential response of NLRP3 to β-glucan and CpG antigens and identifies the NLRP3 inflammasome of human circulating B-lymphocytes as a modulator of the innate and adaptive immune systems.

Canonical Stimulation of the NLRP3 Inflammasome by Fungal Antigens Links Innate and Adaptive B-Lymphocyte Responses by Modulating IL-1β and IgM Production

Inflammasome functional activities in B lymphocytes

Activation and Regulation of NLRP3 by Sterile and Infectious Insults

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity

Regulation of adaptive immunity by the NLRP3 inflammasome.

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis

Caspase-8 Modulates Dectin-1 and Complement Receptor 3–Driven IL-1β Production in Response to β-Glucans and the Fungal Pathogen, Candida albicans

Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra

NLRP3 Inflammasome: Activation, Regulation, and Role in Diseases

The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans.

A Critical Role of NLRP3 Inflammasome in Boosting Antigen-Specific Immunity

Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation

The NLRP3 inflammasome: activation and regulation

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Research Progress of NLRP3 Inflammasome and Adaptive Immunity

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

The Signaling Pathways Regulating NLRP3 Inflammasome Activation

NLRP3 Inflammasome and Inflammatory Bowel Disease

The NLRP3 inflammasome: contributions to inflammation-related diseases